Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma.

Maity G, Ghosh A, Gupta V, Haque I, Sarkar S, Das A, Dhar K, Bhavanasi S, Gunewardena SS, Von Hoff DD, Mallik S, Kambhampati S, Banerjee SK, Banerjee S.

Mol Cancer Ther. 2019 Apr;18(4):788-800. doi: 10.1158/1535-7163.MCT-18-0899. Epub 2019 Feb 20.

PMID:
30787177
2.

Aspirin suppresses tumor cell-induced angiogenesis and their incongruity.

Maity G, Chakraborty J, Ghosh A, Haque I, Banerjee S, Banerjee SK.

J Cell Commun Signal. 2019 Jan 4. doi: 10.1007/s12079-018-00499-y. [Epub ahead of print]

PMID:
30610526
3.

Developmental dental anomalies and their potential role in establishing identity in post-mortem cases: a review.

Puri P, Shukla SK, Haque I.

Med Leg J. 2019 Mar;87(1):13-18. doi: 10.1177/0025817218808714. Epub 2019 Jan 3.

PMID:
30605002
4.

Diprosopus a Rare Craniofacial Malformation.

Bhuyan M, Haque I.

Asian J Neurosurg. 2018 Oct-Dec;13(4):1257-1259. doi: 10.4103/ajns.AJNS_202_17.

5.

Current and future perspectives of liquid biopsies in genomics-driven oncology.

Heitzer E, Haque IS, Roberts CES, Speicher MR.

Nat Rev Genet. 2019 Feb;20(2):71-88. doi: 10.1038/s41576-018-0071-5. Review.

PMID:
30410101
6.

Characteristics and Outcomes of Children with Clinical History of Atopic Versus Non-atopic Asthma Admitted to a Tertiary Pediatric Intensive Care Unit.

Causey J, Gonzales T, Yadav A, Hashmi S, De Jesus-Rojas W, Jon C, Haque I, Johnston R, Stark J, McBeth K, Colasurdo G, Mosquera R.

Open Respir Med J. 2018 May 31;12:21-28. doi: 10.2174/1874306401812010021. eCollection 2018.

7.

Study on Contribution of Biological Interpretable and Computer-Aided Features Towards the Classification of Childhood Medulloblastoma Cells.

Das D, Mahanta LB, Ahmed S, Baishya BK, Haque I.

J Med Syst. 2018 Jul 4;42(8):151. doi: 10.1007/s10916-018-1008-4.

PMID:
29974336
8.

Correction: The population genetics of human disease: The case of recessive, lethal mutations.

Amorim CEG, Gao Z, Baker Z, Diesel JF, Simons YB, Haque IS, Pickrell J, Przeworski M.

PLoS Genet. 2018 Jul 2;14(7):e1007499. doi: 10.1371/journal.pgen.1007499. eCollection 2018 Jul.

9.

Validation of an Expanded Carrier Screen that Optimizes Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant Identification.

Hogan GJ, Vysotskaia VS, Beauchamp KA, Seisenberger S, Grauman PV, Haas KR, Hong SH, Jeon D, Kash S, Lai HH, Melroy LM, Theilmann MR, Chu CS, Iori K, Maguire JR, Evans EA, Haque IS, Mar-Heyming R, Kang HP, Muzzey D.

Clin Chem. 2018 Jul;64(7):1063-1073. doi: 10.1373/clinchem.2018.286823. Epub 2018 May 14.

PMID:
29760218
10.

The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.

Maity G, Haque I, Ghosh A, Dhar G, Gupta V, Sarkar S, Azeem I, McGregor D, Choudhary A, Campbell DR, Kambhampati S, Banerjee SK, Banerjee S.

J Biol Chem. 2018 Mar 23;293(12):4334-4349. doi: 10.1074/jbc.RA117.000333. Epub 2018 Feb 6.

11.

Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.

Haque I, Ghosh A, Acup S, Banerjee S, Dhar K, Ray A, Sarkar S, Kambhampati S, Banerjee SK.

BMC Cancer. 2018 Jan 25;18(1):99. doi: 10.1186/s12885-018-3993-6.

12.

The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review.

Haque I, Subramanian A, Huang CH, Godwin AK, Van Veldhuizen PJ, Banerjee S, Banerjee SK.

Int J Mol Sci. 2017 Dec 31;19(1). pii: E107. doi: 10.3390/ijms19010107. Review.

13.

Experience With Prehospital Damage Control Capability in Modern Conflict: Results From Surgical Resuscitation Team Use.

DuBose JJ, Martens D, Frament C, Haque I, Telian S, Benson PJ.

J Spec Oper Med. Winter 2017;17(4):68-71.

PMID:
29256198
14.

Chemokine (C-C Motif) Receptor-Like 2 is not essential for lung injury, lung inflammation, or airway hyperresponsiveness induced by acute exposure to ozone.

Malik F, Cromar KR, Atkins CL, Price RE, Jackson WT, Siddiqui SR, Spencer CY, Mitchell NC, Haque IU, Johnston RA.

Physiol Rep. 2017 Dec;5(24). pii: e13545. doi: 10.14814/phy2.13545.

15.

Racial disparity in breast cancer: can it be mattered for prognosis and therapy.

Gupta V, Haque I, Chakraborty J, Graff S, Banerjee S, Banerjee SK.

J Cell Commun Signal. 2018 Mar;12(1):119-132. doi: 10.1007/s12079-017-0416-4. Epub 2017 Nov 29. Review.

16.

The population genetics of human disease: The case of recessive, lethal mutations.

Amorim CEG, Gao Z, Baker Z, Diesel JF, Simons YB, Haque IS, Pickrell J, Przeworski M.

PLoS Genet. 2017 Sep 28;13(9):e1006915. doi: 10.1371/journal.pgen.1006915. eCollection 2017 Sep. Erratum in: PLoS Genet. 2018 Jul 2;14(7):e1007499.

17.

Clinical Utility of Expanded Carrier Screening: Reproductive Behaviors of At-Risk Couples.

Ghiossi CE, Goldberg JD, Haque IS, Lazarin GA, Wong KK.

J Genet Couns. 2018 Jun;27(3):616-625. doi: 10.1007/s10897-017-0160-1. Epub 2017 Sep 27.

18.

Using Simulation to Improve Systems-Based Practices.

Gardner AK, Johnston M, Korndorffer JR Jr, Haque I, Paige JT.

Jt Comm J Qual Patient Saf. 2017 Sep;43(9):484-491. doi: 10.1016/j.jcjq.2017.05.006. Epub 2017 Jul 19.

PMID:
28844234
19.

Systematic design and comparison of expanded carrier screening panels.

Beauchamp KA, Muzzey D, Wong KK, Hogan GJ, Karimi K, Candille SI, Mehta N, Mar-Heyming R, Kaseniit KE, Kang HP, Evans EA, Goldberg JD, Lazarin GA, Haque IS.

Genet Med. 2018 Jan;20(1):55-63. doi: 10.1038/gim.2017.69. Epub 2017 Jun 22.

20.

CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen.

Sarkar S, Ghosh A, Banerjee S, Maity G, Das A, Larson MA, Gupta V, Haque I, Tawfik O, Banerjee SK.

Oncogenesis. 2017 May 22;6(5):e340. doi: 10.1038/oncsis.2017.43.

21.

Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.

Das A, Dhar K, Maity G, Sarkar S, Ghosh A, Haque I, Dhar G, Banerjee S, Banerjee SK.

Sci Rep. 2017 Apr 27;7(1):1220. doi: 10.1038/s41598-017-00916-z.

22.

A system-wide movement to improve patient care and reduce unnecessary laboratory testing.

Eamranond P, Joshi M, Haque I, Scarry A, Geary S, Collins B.

MLO Med Lab Obs. 2017 Apr;49(4):46-7. No abstract available.

PMID:
29979015
23.

Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods.

Artieri CG, Haverty C, Evans EA, Goldberg JD, Haque IS, Yaron Y, Muzzey D.

Prenat Diagn. 2017 May;37(5):482-490. doi: 10.1002/pd.5036. Epub 2017 Apr 26.

PMID:
28317136
24.

Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment.

Vysotskaia VS, Hogan GJ, Gould GM, Wang X, Robertson AD, Haas KR, Theilmann MR, Spurka L, Grauman PV, Lai HH, Jeon D, Haliburton G, Leggett M, Chu CS, Iori K, Maguire JR, Ready K, Evans EA, Kang HP, Haque IS.

PeerJ. 2017 Feb 23;5:e3046. doi: 10.7717/peerj.3046. eCollection 2017.

25.

Smith-Lemli-Opitz syndrome carrier frequency and estimates of in utero mortality rates.

Lazarin GA, Haque IS, Evans EA, Goldberg JD.

Prenat Diagn. 2017 Apr;37(4):350-355. doi: 10.1002/pd.5018. Epub 2017 Mar 9.

26.

Prenatal Carrier Screening.

Haque IS, Lazarin GA, Wapner RJ.

JAMA. 2016 Dec 27;316(24):2675-2676. doi: 10.1001/jama.2016.17401. No abstract available.

PMID:
28027359
27.

Ventricular Fibrillation-Induced Cardiac Arrest Results in Regional Cardiac Injury Preferentially in Left Anterior Descending Coronary Artery Territory in Piglet Model.

Venkata GK, Forder JR, Clark D, Shih A, Udassi S, Badugu S, Lamb MA, Porvasnik SL, Shih RS, Colon-Lopez D, Zaritsky AL, Haque IU, Udassi JP.

Biomed Res Int. 2016;2016:5958196. Epub 2016 Nov 2.

28.

Corrigendum: A novel transcription factor-like gene SbSDR1 acts as a molecular switch and confers salt and osmotic endurance to transgenic tobacco.

Singh VK, Mishra A, Haque I, Jha B.

Sci Rep. 2016 Nov 10;6:35128. doi: 10.1038/srep35128. No abstract available.

29.

Plasminogen activator inhibitor-1 does not contribute to the pulmonary pathology induced by acute exposure to ozone.

Elkhidir HS, Richards JB, Cromar KR, Bell CS, Price RE, Atkins CL, Spencer CY, Malik F, Alexander AL, Cockerill KJ, Haque IU, Johnston RA.

Physiol Rep. 2016 Sep;4(18). pii: e12983.

30.

Objective Evaluation of the Effects of Deployment on Laparoscopic Skills: The Simulation and Deployment Laparoscopic Skills Study.

Deering SH, Kavanagh LB, Chinn MK, Choi Y, Rush RM Jr, Haque I.

Mil Med. 2016 Sep;181(9):1058-64. doi: 10.7205/MILMED-D-15-00265.

PMID:
27612353
31.
32.

Human pancreatic cancer progression: an anarchy among CCN-siblings.

Banerjee SK, Maity G, Haque I, Ghosh A, Sarkar S, Gupta V, Campbell DR, Von Hoff D, Banerjee S.

J Cell Commun Signal. 2016 Sep;10(3):207-216. Epub 2016 Aug 19.

33.

Group Testing Approach for Trinucleotide Repeat Expansion Disorder Screening.

Kaseniit KE, Theilmann MR, Robertson A, Evans EA, Haque IS.

Clin Chem. 2016 Oct;62(10):1401-8. doi: 10.1373/clinchem.2016.259796. Epub 2016 Aug 18.

34.

Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening.

Haque IS, Lazarin GA, Kang HP, Evans EA, Goldberg JD, Wapner RJ.

JAMA. 2016 Aug 16;316(7):734-42. doi: 10.1001/jama.2016.11139.

PMID:
27533158
35.

Re: Carrier Screening is a Deficient Strategy for Determining Sperm Donor Eligibility and Reducing Risk of Disease in Recipient Children (From: Silver AJ, Larson JL, Silver MJ, et al. Genet Test Mol Biomarkers 2016;20:276-284).

Wong KK, Goldberg JD, Evans EA, Kang HP, Haque IS.

Genet Test Mol Biomarkers. 2016 Aug;20(8):413-4. doi: 10.1089/gtmb.2016.29019.kkw. No abstract available.

PMID:
27505438
36.

Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing.

Kang HP, Maguire JR, Chu CS, Haque IS, Lai H, Mar-Heyming R, Ready K, Vysotskaia VS, Evans EA.

PeerJ. 2016 Jun 28;4:e2162. doi: 10.7717/peerj.2162. eCollection 2016.

37.

Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population.

Mehta N, Lazarin GA, Spiegel E, Berentsen K, Brennan K, Giordano J, Haque IS, Wapner R.

Genet Test Mol Biomarkers. 2016 Sep;20(9):504-9. doi: 10.1089/gtmb.2015.0302. Epub 2016 Jun 30.

38.

The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression.

Hawa Z, Haque I, Ghosh A, Banerjee S, Harris L, Banerjee SK.

Int J Mol Sci. 2016 May 26;17(6). pii: E809. doi: 10.3390/ijms17060809. Review.

39.

Is There a Role for the Enteral Administration of Serum-Derived Immunoglobulins in Human Gastrointestinal Disease and Pediatric Critical Care Nutrition?

Van Arsdall M, Haque I, Liu Y, Rhoads JM.

Adv Nutr. 2016 May 16;7(3):535-43. doi: 10.3945/an.115.011924. Print 2016 May. Review.

40.

Expanded carrier screening: A review of early implementation and literature.

Lazarin GA, Haque IS.

Semin Perinatol. 2016 Feb;40(1):29-34. doi: 10.1053/j.semperi.2015.11.005. Epub 2015 Dec 21. Review.

41.

Resistin deficiency in mice has no effect on pulmonary responses induced by acute ozone exposure.

Razvi SS, Richards JB, Malik F, Cromar KR, Price RE, Bell CS, Weng T, Atkins CL, Spencer CY, Cockerill KJ, Alexander AL, Blackburn MR, Alcorn JL, Haque IU, Johnston RA.

Am J Physiol Lung Cell Mol Physiol. 2015 Nov 15;309(10):L1174-85. doi: 10.1152/ajplung.00270.2015. Epub 2015 Sep 18.

42.

Evaluation of potential drug - drug interactions in general medicine ward of teaching hospital in southern India.

Ahmad A, Khan MU, Haque I, Ivan R, Dasari R, Revanker M, Pravina A, Kuriakose S.

J Clin Diagn Res. 2015 Feb;9(2):FC10-3. doi: 10.7860/JCDR/2015/11264.5608. Epub 2015 Feb 1.

43.

Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels.

Lazarin GA, Hawthorne F, Collins NS, Platt EA, Evans EA, Haque IS.

PLoS One. 2014 Dec 10;9(12):e114391. doi: 10.1371/journal.pone.0114391. eCollection 2014.

44.

CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation.

Haque I, Banerjee S, De A, Maity G, Sarkar S, Majumdar M, Jha SS, McGragor D, Banerjee SK.

Oncogene. 2015 Jun 11;34(24):3152-63. doi: 10.1038/onc.2014.250. Epub 2014 Aug 18.

PMID:
25132260
45.

Curvelet based offline analysis of SEM images.

Shirazi SH, Haq Nu, Hayat K, Naz S, Haque Iu.

PLoS One. 2014 Aug 4;9(8):e103942. doi: 10.1371/journal.pone.0103942. eCollection 2014.

46.

Effect of antigen sensitization and challenge on oscillatory mechanics of the lung and pulmonary inflammation in obese carboxypeptidase E-deficient mice.

Dahm PH, Richards JB, Karmouty-Quintana H, Cromar KR, Sur S, Price RE, Malik F, Spencer CY, Barreno RX, Hashmi SS, Blackburn MR, Haque IU, Johnston RA.

Am J Physiol Regul Integr Comp Physiol. 2014 Sep 15;307(6):R621-33. doi: 10.1152/ajpregu.00205.2014. Epub 2014 Jul 9.

47.

Pancreatic tumor cell secreted CCN1/Cyr61 promotes endothelial cell migration and aberrant neovascularization.

Maity G, Mehta S, Haque I, Dhar K, Sarkar S, Banerjee SK, Banerjee S.

Sci Rep. 2014 May 16;4:4995. doi: 10.1038/srep04995.

48.

Cloud service selection using multicriteria decision analysis.

Whaiduzzaman M, Gani A, Anuar NB, Shiraz M, Haque MN, Haque IT.

ScientificWorldJournal. 2014 Feb 13;2014:459375. doi: 10.1155/2014/459375. eCollection 2014. Review.

49.

Characterization and functional analysis of eugenol O-methyltransferase gene reveal metabolite shifts, chemotype specific differential expression and developmental regulation in Ocimum tenuiflorum L.

Renu IK, Haque I, Kumar M, Poddar R, Bandopadhyay R, Rai A, Mukhopadhyay K.

Mol Biol Rep. 2014 Mar;41(3):1857-70. doi: 10.1007/s11033-014-3035-7. Epub 2014 Jan 14.

PMID:
24420851
50.

SCISSORS: practical considerations.

Kearnes SM, Haque IS, Pande VS.

J Chem Inf Model. 2014 Jan 27;54(1):5-15. doi: 10.1021/ci400264f. Epub 2013 Dec 16.

Supplemental Content

Support Center